Gynaecologists has regularly convened Study Groups to address important growth areas within obstetrics and gynaecology. An international group of eminent clinicians and scientists from various disciplines is invited to present the results of recent research and to take part in in-depth discussions. The resulting volume, containing enhanced versions of the papers presented, is published within a few months of the meeting and provides a summary of the subject that is both authoritative and up to date. No part of this publication may be reproduced, stored or transmitted in any form or by any means, without the prior written permission of the publisher or, in the case of reprographic reproduction, in accordance with the terms of licences issued by the Copyright Licensing Agency in the UK [www.cla.co.uk]. Enquiries concerning reproduction outside the terms stated here should be sent to the publisher at the UK address printed on this page.
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While every eff ort has been made to ensure the accuracy of the information contained within this publication, the publisher can give no guarantee for information about drug dosage and application thereof contained in this book. In every individual case the respective user must check current indications and accuracy by consulting other pharmaceutical literature and following the guidelines laid down by the manufacturers of specifi c products and the relevant authorities in the country in which they are practising. 
Preface
Polycystic ovary syndrome (PCOS) is a heterogeneous collection of signs and symptoms that, gathered together, form a spectrum of a disorder with a mild presentation in some, whereas in others there may be a severe disturbance of reproductive, endocrine and metabolic function. The definition of the syndrome has been much debated, with key features including menstrual cycle disturbance, hyperandrogenism and obesity. The pathophysiology of PCOS appears to be multifactorial and polygenic and is still being actively researched. PCOS is the most common endocrine disturbance and affects 10-15% of women in the UK. The clinical findings of hirsutism, acne, alopecia and obesity do not always correlate with the serum biochemistry, which itself may be difficult to assess. There is no doubt that PCOS has a significant effect on quality of life and psychological morbidity and, as many specialists may be involved in its management, a multidisciplinary approach is required. The 59th RCOG Study Group brought together a wide range of experts who treat women with PCOS and the clinical conditions related to the syndrome. The actual definition, the accuracy of diagnostic investigations, the particular challenges in adolescent diagnosis and management, the relationship with ethnicity and issues relating to the clinical care of women with PCOS are all covered in this comprehensive book.
Importantly, there is a critical evaluation of current approaches to therapy, a discussion on the potential individualisation of therapy (regarding the identification of those who will -or will not -respond to fertility interventions) and a chapter on the role of alternative therapies, which are employed in managing some aspects of this syndrome.
For those caring for women with PCOS, be it in primary or secondary care, this book should prove both interesting and a valuable tool in increasing the knowledge base and facilitating the decision-making process.
